164 related articles for article (PubMed ID: 31257091)
1. The effect of maternal use of telbivudine on neonatal CD4
Liang X; Liu P; He Z; Chen X; Xiao X
Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):195-203. PubMed ID: 31257091
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real-life practice.
Liu J; Wang J; Yan T; Du D; Qi C; Cao F; Yao N; Yang Y; He Y; Tian Z; Ren D; Zhu L; Chen T; Zhao Y
J Viral Hepat; 2019 Oct; 26(10):1170-1177. PubMed ID: 31177596
[TBL] [Abstract][Full Text] [Related]
3. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of nucleos(t)ide analogues to prevent hepatitis B virus mother-to-child transmission in pregnant women with high viremia: real life practice from China.
Sheng Q; Ding Y; Li B; Han C; Li Y; Zhang C; Bai H; Wang J; Zhao L; Xia T; An Z; Zhang M; Dou X
Int J Med Sci; 2018; 15(8):796-801. PubMed ID: 30008589
[No Abstract] [Full Text] [Related]
5. Efficacy and safety of telbivudine to prevent mother-to-child transmission of hepatitis B virus in middle- and late-stage pregnancy with high viral loads.
Xu J; Tao LL; Ma LX
J Med Virol; 2019 Dec; 91(12):2153-2157. PubMed ID: 31397488
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China: An observational study.
Sheng QJ; Wang SJ; Wu YY; Dou XG; Ding Y
Medicine (Baltimore); 2018 Jun; 97(22):e10931. PubMed ID: 29851831
[TBL] [Abstract][Full Text] [Related]
7. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.
Han GR; Cao MK; Zhao W; Jiang HX; Wang CM; Bai SF; Yue X; Wang GJ; Tang X; Fang ZX
J Hepatol; 2011 Dec; 55(6):1215-21. PubMed ID: 21703206
[TBL] [Abstract][Full Text] [Related]
8. Developmental consequences of children born from mothers with telbivudine treatment during late pregnancy: A prospective study with 3-year follow-up.
Yi W; Cao X; Zeng Z; Cao W; Zhang Y; Sun F; Wang Y; Wan G; Li M; Xie Y
Virulence; 2021 Dec; 12(1):1527-1537. PubMed ID: 34120564
[TBL] [Abstract][Full Text] [Related]
9. Telbivudine Treatment during Late Pregnancy Prevents Mother-to-Child Transmission of Hepatitis B Virus: A Retrospective Study.
Cai M; Hao Y; Zhong J; Yao W; Cao X; Gu G; Qin G
Can J Gastroenterol Hepatol; 2019; 2019():9046260. PubMed ID: 31380321
[TBL] [Abstract][Full Text] [Related]
10. Telbivudine treatment of hepatitis B virus-infected pregnant women at different gestational stages for the prevention of mother-to-child transmission: Outcomes of telbivudine treatment during pregnancy.
Tan Z; Yin Y; Zhou J; Wu L; Xu C; Hou H
Medicine (Baltimore); 2016 Oct; 95(40):e4847. PubMed ID: 27749537
[TBL] [Abstract][Full Text] [Related]
11. Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission.
Sun W; Zhao S; Ma L; Hao A; Zhao B; Zhou L; Li F; Song M
BMC Gastroenterol; 2017 Apr; 17(1):51. PubMed ID: 28407735
[TBL] [Abstract][Full Text] [Related]
12. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice.
Zhang H; Pan CQ; Pang Q; Tian R; Yan M; Liu X
Hepatology; 2014 Aug; 60(2):468-76. PubMed ID: 25187919
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus.
Zhu B; Lv X; Zhao Z; Chen L; Chen X; Li C; Li S; Dai E
Medicine (Baltimore); 2021 Nov; 100(44):e27695. PubMed ID: 34871254
[TBL] [Abstract][Full Text] [Related]
14. Safety of telbivudine treatment for chronic hepatitis B for the entire pregnancy.
Liu M; Cai H; Yi W
J Viral Hepat; 2013 Apr; 20 Suppl 1():65-70. PubMed ID: 23458527
[TBL] [Abstract][Full Text] [Related]
15. [Telbivudine for prevention of perinatal transmission in pregnant women infected with hepatitis B virus in immune-tolerant phase: a study of efficacy and safety of drug withdrawal].
Sheng QJ; Ding Y; Li BJ; Bai H; Zhang C; Han C; Fan YX; Li YW; Dou XG
Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):258-64. PubMed ID: 27470623
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of telbivudine treatment for the prevention of HBV perinatal transmission.
Ren C; Wang L; Sun W; Ma L; Dong Z; Hao A; Zhou L; Li F; Ma W
Medicine (Baltimore); 2020 Jun; 99(24):e20583. PubMed ID: 32541488
[TBL] [Abstract][Full Text] [Related]
17. Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B.
Pan CQ; Han GR; Jiang HX; Zhao W; Cao MK; Wang CM; Yue X; Wang GJ
Clin Gastroenterol Hepatol; 2012 May; 10(5):520-6. PubMed ID: 22343511
[TBL] [Abstract][Full Text] [Related]
18. Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus.
Yu MM; Jiang Q; Ji Y; Wu KH; Ju LL; Tang X; Yang YF
J Clin Virol; 2014 Sep; 61(1):55-60. PubMed ID: 24994007
[TBL] [Abstract][Full Text] [Related]
19. Comparison of tenofovir disoproxil fumarate and telbivudine in preventing hepatitis B transmission in mothers with high viral load.
Wang M; Ran R; Zhu Y; Zhang H
Int J Gynaecol Obstet; 2023 Feb; 160(2):646-652. PubMed ID: 35816243
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of tenofovir disoproxil fumarate or telbivudine used throughout pregnancy for the prevention of mother-to-child transmission of hepatitis B virus: A cohort study.
Li Z; Xie B; Yi N; Cai H; Yi W; Gao X
Eur J Obstet Gynecol Reprod Biol; 2022 Sep; 276():102-106. PubMed ID: 35853269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
